Page last updated: 2024-08-24

lifibrol and Hyperlipidemias

lifibrol has been researched along with Hyperlipidemias in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, FP1
Friedrich, I; Klima, B; Köster, W; März, W; Nuber, C; Sattler, A; Schäfer, JR; Steinmetz, A; Wieland, H; Winkler, K1

Trials

1 trial(s) available for lifibrol and Hyperlipidemias

ArticleYear
Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.
    Atherosclerosis, 1999, Volume: 144, Issue:1

    Topics: Adult; Anticholesteremic Agents; Apolipoproteins B; Butanols; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxybenzoates; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome

1999

Other Studies

1 other study(ies) available for lifibrol and Hyperlipidemias

ArticleYear
Effect of the lipid-lowering drug lifibrol on lipid metabolism in rat macrophages and in atherosclerotic arteries from swine and WHHL rabbits, in vitro. Implications in atherogenesis.
    Biochemical pharmacology, 1993, Oct-19, Volume: 46, Issue:8

    Topics: Acetates; Animals; Aorta; Arteries; Arteriosclerosis; Butanols; Carbon Radioisotopes; Cholesterol; Hydroxybenzoates; Hyperlipidemias; Hypolipidemic Agents; Lipids; Macrophages, Peritoneal; Male; Oleic Acid; Oleic Acids; Rabbits; Rats; Rats, Sprague-Dawley; Swine

1993